A Vaccine Breakthrough

0 Anmeldelser
0
Episode
938 of 2597
Længde
25M
Sprog
Engelsk
Format
Kategori
Fakta

It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.

But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine is 90 percent effective in preventing Covid-19.

With the virus raging, how strong is this new ray of hope?

Guest: Carl Zimmer, a science writer and author of the “Matter” column for The New York Times.

Background reading:

• Pfizer has announced positive early results • from its coronavirus vaccine trial, cementing the lead in a frenzied global race that has unfolded at record-breaking speed. Meet the couple • behind the German company, BioNTech, that partnered with Pfizer to develop the vaccine.

We want to hear from you. Fill out our survey about this show and others at nytimes.com/thedailysurvey.

Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036

Other podcasts you might like ...